+40.0%
CVS vs IBKR
+1,011.6%
-971.6%
-56.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | IBKR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | +2.2% | -2.8% | -1.1% |
| 7D | -2.2% | -1.3% | -0.8% | -1.9% |
| 30D | -0.1% | -0.2% | +0.2% | -0.3% |
| 3M | -5.2% | +3.0% | -8.2% | -6.3% |
| 6M | +26.9% | +33.9% | -7.0% | +18.6% |
| YTD | +22.1% | +42.5% | -20.4% | +12.1% |
| 1Y | +30.8% | +44.9% | -14.1% | +19.2% |
| 3Y | +54.4% | +293.0% | -238.6% | +8.4% |
| 5Y | +33.4% | +497.7% | -464.3% | -18.2% |
| All | +40.0% | +1,011.6% | -971.6% | -28.5% |
Cumulative growth
Daily Returns
Daily percentage return beside IBKR.
Daily Out/Under-Performance
Portfolio return minus IBKR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IBKR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded IBKR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling